Pricing Log in Create free account

Curis, Inc. (CRIS) vs Atrinsic Inc. (PTIX)

Curis, Inc. and Atrinsic Inc. are both Biotechnology companies. Atrinsic Inc. is the larger, with a market value of $1.3M against $1.1M — 1.2× the size. Curis, Inc. has negative trailing earnings, so its P/E is not meaningful; Atrinsic Inc. trades at 0.3×. Across the 10 metrics below, Atrinsic Inc. leads on 6 and Curis, Inc. on 4.

Valuation

Metric CRIS PTIX Biotechnology median
P/E n/m 0.34 8.50
P/S 0.09 n/m 9.71
P/B 0.19 0.79 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.41 n/m 0.64
EV/Sales (0.37) n/m 9.21
Earnings yield (3,468.29%) 297.33% (33.15%)
Free cash flow yield (3,540.29%) (158.74%) (25.50%)

Profitability

Metric CRIS PTIX Biotechnology median
Gross margin 99.52% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 455.35% (338.24%) (56.36%)
Return on assets (87.76%) 378.63% (48.04%)
Return on invested capital 0.00% (229.86%) 0.00%

Growth

Metric CRIS PTIX Biotechnology median
Revenue growth (TTM) (13.43%) — 6.02%
EPS growth (last fiscal year) 91.57% 188.24% 30.26%
Revenue growth, 5-year CAGR (2.71%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRIS PTIX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.49 0.66 4.72
Net debt to EBITDA 0.91 0.52 0.96

Dividend

Metric CRIS PTIX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CRIS PTIX Biotechnology median
Market cap 1.06m 1.27m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack